IHS Chemical Week

Chemical Week Magazine :: Newsbriefs

Monsanto Seeks $100 Million in Damages from Novartis

1:03 PM MDT | August 8, 2007 | Chemical Week Editorial Staff

Monsanto says it has filed an arbitration claim against Novartis subsidiary Sandoz (Vienna) with the International Chamber of Commerce (Paris) over “quality assurance failures” at Sandoz’s Kundl, Austria pharmaceutical facility. Monsanto sources Posilac, an animal pharmaceutical supplement, from this facility. Monsanto says it is seeking $100 million in damages to compensate for “significant financial injury” resulting from supply disruptions to Monsanto customers that occurred while Sandoz was bringing its plant up to U.S. FDA...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa